Research Assistant Position at the Targeted Therapeutics and Nanodevices Research Group
RA-SM // Deadline: 16/07/2026
RA-SM // Deadline: 16/07/2026
The research, led by the Institute for Bioengineering of Catalonia, reveals that the blood–brain barrier is defined not only by the proteins it expresses, but by how it uses them, through a dynamic property known as endocytic turnover rate (ETOR). This discovery shows that brain endothelial cells have a unique molecular behaviour that distinguishes them from other blood vessels and can be disrupted during inflammation. The results provide new insight into how the barrier functions and fails in disease which may help identify novel therapeutic strategies to restore neurovascular health.
The OPTOGEN conference brings together the most active scientists and technologists to discuss recent progresses and future challenges in technologies for in vivo optogenetics and optical neural interfaces: from new … Read more
Constructing Biological Complexity: Engineering Interactions Across Scales Biological systems achieve remarkable functionality through interactions that span multiple scales, from molecular assemblies and cellular compartments to tissues and complex microenvironments. Understanding … Read more
Ways of Seeing Nature is a master designer, shaping molecules, materials, organisms, and ecosystems through interactions across scales. Yet many of its most remarkable strategies remain hidden in plain sight, waiting to … Read more
JDS-SM // Deadline: 24/07/2026
JAC-SM // Deadline: 24/07/2026
In June, the IBEC management team took part in an exchange visit to the UCL Hawkes Institute as part of the Severo Ochoa programme. Currently in its pilot phase, this initiative opens up new opportunities for knowledge and best practice sharing in research management amongst leading international institutions.
On 18 June, the results were announced for the 36 research projects funded by La Marató de 3Cat through its 2020 special call for proposals dedicated to tackling the novel coronavirus (SARS-CoV-2). The Institute for Bioengineering of Catalonia (IBEC) participated in three of these projects, which aimed to deepen our understanding of the disease and improve its diagnosis and clinical monitoring.